Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-08-01
2006-08-01
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S406000, C514S438000, C514S445000, C514S522000, C514S530000, C514S538000, C514S542000, C548S371400, C558S413000, C549S068000, C549S077000, C560S012000, C560S013000, C564S089000, C564S090000
Reexamination Certificate
active
07084178
ABSTRACT:
A series of N-cycloalkylcarboxamide derivatives of N-benzyl benzenesulfonamides of Formula I are described.The compounds inhibit β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions characterized by aberrant extracellular deposition of β-amyloid. Pharmaceutical compositions and methods of treatment using these compounds are also disclosed.
REFERENCES:
patent: 5276169 (1994-01-01), Kunisch et al.
patent: 5321042 (1994-06-01), Mittendorf et al.
patent: 5631291 (1997-05-01), Mittendorf et al.
patent: 5739160 (1998-04-01), Mittendorf et al.
patent: 5770622 (1998-06-01), Mittendorf et al.
patent: 5962724 (1999-10-01), Mittendorf et al.
patent: 19548825 (1995-12-01), None
patent: WO 95/19337 (1995-07-01), None
patent: WO 00/46189 (2000-08-01), None
W.L.F. Armarego, et al, “Quinazolines. Part XX. Synthesis and Stereochemistry of N-Methyl-cis-Perhydroquinazolin-2-Ones and N-Methyl-cis-Perhydroquinazolines; a New Conformation for cis-Perhydroquinazolines,” J. Chem. Soc. Perkin Trans. 1, pp. 2313-2319, 1974.
J.I. Levin, et al, “Heteroaryl and Cycloalkyl Sulfonamide Hydroxamic Acid Inhibitors of Matrix Metalloproteinases,” Bioorganic & Medicinal Chemistry Letters, 11, pp. 239-242, 2001.
Preiml, M., et al, “A New Approach to β-Amino Acids: Biotransformation of N-Protected β-Amino Nitriles,” Tetrahedron Letters, 44, pp. 5057-5059, 2003.
Higgins Mendi A.
Marcin Lawrence R.
Bristol--Myers Squibb Company
Epperson James
O'Sullivan Peter
LandOfFree
Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3647386